TNF and Alzheimer disease: Cryptotanshinone ameliorated secretion of TNF-α and IL-1β, infiltration of immune cells into skin lesions in DNCB-induced AD-like skin lesions in vivo and inhibited mast cell degranulation by IgE in vitro via inhibition of Syk and Lyn kinases [34].